Aktualności
MHRA: An innovative approach to developing malaria vaccine
12.03.2015
The Medicines and Healthcare products Regulatory Agency (MHRA) has today published its fourth case study detailing how the regulator has helped researchers at the Jenner Institute, University of
...
URPL: Announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 4, 2015 on the amendment of change the granted period of initiation of the DCP / MRP of the Polish Republic as the refere
12.03.2015
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 4, 2015 on the amendment of change the granted
...
URPL: Announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 4, 2015 on the accession the Voluntary Harmonization Procedure (VHP) in clinical trials.
12.03.2015
This document is announcement of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of March 4, 2015 on the accession the Voluntary
...
FDA: Complicated Urinary Tract Infections: Developing Drugs for Treatment, Guidance for Industry
05.03.2015
The purpose of this guidance is to assist sponsors in the clinical development of drugs for the treatment of complicated urinary tract infections (cUTIs). Specifically, this guidance addresses the
...
RAPS: FDA to Study Quality of Long-Acting Generic Drug Products, Including Popular Birth Control Drug
05.03.2015
The US Food and Drug Administration (FDA) is prepared to spend nearly a million dollars over the next two years to study the quality and effectiveness of long-acting generic drug products,
...
RAPS: Asia Regulatory Roundup: India\'s CDSCO May Soon Regulate Devices (18 February 2015)
05.03.2015
CDSCO Readies to Take Control of Medical Devices as Pricing Row Escalates The Central Drugs Standard Control Organization (CDSCO) will gain oversight of medical devices if a proposed legislative
...
GMP: Requirements for Risk Analyses in the Regulatory Submission Dossier: EMA\'s and FDA\'s Recommendations
05.03.2015
The EMA has published a new question & answer-(Q&A) paper together with the FDA at the end of 2014. This document answers questions on detailed requirements in connection with the documents
...
GMP: Supply Chain: A Series of new Regulations in Force
05.03.2015
The new EU Directive 2011/62/EU and its delegated acts keep on changing the pharmaceutical supply chain. The directive introduced numerous Delegated Acts with different time schedules and had some
...
GMP: GMP Data Integrity: New MHRA Guideline
05.03.2015
The MHRA announced in January 2014 that the pharmaceutical industry is expected to review data integrity within the frame of self inspections.
Now, a Guideline of the MHRA on data integrity was
...
URPL: Information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 10, 2015 concerning reporting adverse reactions to medicinal products
26.02.2015
This document is an information of President of The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of February 10, 2015 concerning reporting adverse reactions
...
